scispace - formally typeset
M

Maria Angeles Mena

Researcher at Columbia University

Publications -  66
Citations -  13022

Maria Angeles Mena is an academic researcher from Columbia University. The author has contributed to research in topics: Dopamine & Parkin. The author has an hindex of 35, co-authored 66 publications receiving 11502 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

TL;DR: It is shown that inactivation of the parkin gene in mice results in motor and cognitive deficits, inhibition of amphetamine-induced dopamine release and inhibition of glutamate neurotransmission, and the levels of dopamine are increased in the limbic brain areas of parkin mutant mice and there is a shift towards increased metabolism of dopamine by MAO.
Journal ArticleDOI

Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.

TL;DR: This study develops and characterized a mouse model of tauopathy with parkinsonism, overexpressing human mutated tau protein with deletion of parkin, and opens the way for clinical studies of the effects of trehalose in human tauopathies.
Journal ArticleDOI

Neurotoxicity of levodopa on catecholamine-rich neurons.

TL;DR: Treatment with deprenyl, an inhibitor of monoamine oxidase type B, partially prevented levodopa neurotoxicity, suggesting that the mechanism of toxicity was, at least in part, related to an increase in the metabolism of dopamine catalyzed by monoamines oxidase.